Expression of autocrine motility factor correlates with the angiogenic phenotype of and poor prognosis for human gastric cancer

Clinical Cancer Research

Volumn 11, Issue 16, 2005, Pages 5778-5783

  Gong, Weida ^a   Jiang, Yixing ^a   Wang, Liwei ^a   Wei, Daoyan ^a   Yao, James ^a   Huang, Suyun ^a   Fang, Shengyun ^b   Xie, Keping ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOCRINE MOTILITY FACTOR; AUTOCRINE MOTILITY FACTOR RECEPTOR; CYTOKINE; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CELL MOTILITY; CONTROLLED STUDY; DENSITY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MICROVESSEL DENSITY; NONBIOLOGICAL MODEL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR VASCULARIZATION;

ANTIGENS, CD34; AUTOCRINE MOTILITY FACTOR; BLOTTING, WESTERN; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 23844486742     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0214     Document Type: Article

References (35)

1. Funasaka T, Haga A, Raz A, Nagase H. Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells. Int J Cancer 2002;101:217-23.
2. Otto T, Bex A, Schmidt U, Raz A, Rubben H. Improved prognosis assessment for patients with bladder carcinoma. Am J Pathol 1997;150:1919-23.
3. Hirono Y, Fushida S, Yonemura Y, Yamamoto H, Watanabe H, Raz A. Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer. Br J Cancer 1996;74:2003-7.
4. Maruyama K, Watanabe H, Shiozaki H, et al. Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma. Int J Cancer 1995;64:316-21.
5. Levine MD, Liotta LA, Stracke ML. Stimulation and regulation of tumor cell motility in invasion and metastasis. EXS 1995;74:157-79.
6. Nakamori S, Watanabe H, Kameyama M, et al. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence. Cancer 1994;74:1855-62.
7. Nabi IR, Watanabe H, Raz A. Autocrine motility factor and its receptor: role in cell locomotion and metastasis. Cancer Metastasis Rev 1992;11:5-20.
8. Liotta LA, Stracke ML, Aznavoorian SA, Beckner ME, Schiffmann E. Tumor cell motility. Semin Cancer Biol 1991;2:111-4.
9. Stracke ML, Aznavoorian SA, Beckner ME, Liotta LA, Schiffmann E. Cell motility, a principal requirement for metastasis. EXS 1991;59:147-62.
10. Nabi IR, Watanabe H, Silletti S, Raz A. Tumor cell autocrine motility factor receptor. EXS 1991;59:163-77.
11. Rosen EM, Goldberg ID. Protein factors which regulate cell motility. In Vitro Cell Dev Biol 1989;25:1079-87.
12. Partin AW, Schoeniger JS, Mohler JL, Coffey DS. Fourier analysis of cell motility: correlation of motility with metastatic potential. Proc Natl Acad Sci U S A 1989;86:1254-8.
13. Volk T, Geiger B, Raz A. Motility and adhesive properties of high- and low-metastatic murine neoplastic cells. Cancer Res 1984;44:811-24.
14. Wang L, Wei D, Le X, et al. Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 2003;9:6371-80.
15. Wei D, Gong W, Kanai M, et al. Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 2005;65:2746-54.
16. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
17. Yao JC, Wang L, Wei D, et al. Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res 2004;10:4109-17.
18. Wang L, Quan X, Gong W, et al. Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer. Clin Exp Metastasis. In press 2005.
19. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
20. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet 1992;340:145-6.
21. Gasparini G, Weidner N, Maluta S, et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous cell carcinoma, Int J Cancer 1993;55:739-44.
22. Wakui S, Furusato M, Itoh T et al. Tumour angiogenesis in prostatic carcinoma with and without bone metastasis: a morphometric study. J Pathol 1992;168:257-62.
23. Olivarez D, Ulbright T, DeRieseW, et al. Neovascularization in clinical stage A testicular germ cell tumor: prediction of metastatic disease. Cancer Res 1994;54:2800-2.
24. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-7.
25. Giatromanolaki A, Koukourakis MI, Stathopoulos GP, et al. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer. Oncol Res 2000;12:33-41.
26. Takahashi R, Tanaka S, Kitadai Y, et al. Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncology 2003;64:266-74.
27. Du JR, Jiang Y, Zhang YM, Fu H. Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas. World J Gastroenterol 2003;9:1604-6.
28. Kim HS, Kang HS, Messam CA, Min KW, Park CS. Comparative evaluation of angiogenesis in gastric adenocarcinoma by nestin and CD34. Appl Immunohistochem Mol Morphol 2002;10:121-7.
29. Lu M, Jiang Y, Wang R. The relationship of vascular endothelial growth factor and angiogenesis to the progression of gastric carcinoma. Zhonghua Bing Li Xue Za Zhi 1998;27:278-81.
30. Joo YE, Sohn YH, Joo SY, et al. The role of vascular endothelial growth factor (VEGF) and p53 status for angiogenesis in gastric cancer. Korean J Intern Med 2002;17:211-9.
31. Sanz-Ortega J, Steinberg SM, Moro E, et al. Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFR as prognostic factors in gastric cancer. Histol Histopathol 2000;15:455-62.
32. Tenderenda M, Rutkowski P, Jesionek-Kupnicka D, Kubiak R. Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index. Pathol Oncol Res 2001;7:129-34.
33. Xie K, Wei D, Shi Q, Huang S. Constitutive and inducible expression and regulation of vascular endothelial growth factor. Cytokine Growth Factor Rev 2004;15:297-324.
34. Tsutsumi S, Yanagawa T, Shimura T, Kuwano H, Raz A. Autocrine motility factor signaling enhances pancreatic cancer metastasis. Clin Cancer Res 2004;10:7775-84.
35. Yoon DY, Buchler P, Saarikoski ST, Hines OJ, Reber HA, Hankinson O. Identification of genes differentially induced by hypoxia in pancreatic cancer cells. Biochem Biophys Res Commun 2001;288:882-6.